Hims & Hers Health to acquire Australia's Eucalyptus for up to $1.15 billion

Hims & Hers Health announced plans to acquire Australia's Eucalyptus in a deal valued at up to $1.15 billion, aiming to establish a presence in Australia and Japan while expanding its footprint in the United Kingdom, Germany, and Canada. This strategic acquisition represents a significant international expansion for the American telehealth company, which has primarily focused on the US market since its founding. The deal would allow Hims & Hers to leverage Eucalyptus's existing infrastructure and customer base in key Asian and European markets, accelerating their global growth strategy. The acquisition comes amid increasing consolidation in the digital health sector as companies seek to expand their geographic reach and service offerings. Industry analysts view this move as a bold step for Hims & Hers to compete with larger global healthcare providers and diversify beyond their core men's and women's health products. The deal structure includes performance-based components that could increase the total consideration to $1.15 billion, indicating confidence in Eucalyptus's growth potential within the combined entity.